Hepatitis B elimination in children of Slovenian origin born in Slovenia after the introduction of preventive strategies: The results of a national study

1 WHO. Global hepatitis report, 2017. Accessed March 7th, 2021 at: http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/WHO Global hepatitis report 2017 Accessed March 7th, 2021 at http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/Search in Google Scholar

2 Locarnini S, Hatzakis A, Chen DS, Lok A. Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs. J Hepatol. 2015;62:S76-86. doi: 10.1016/j.jhep.2015.01.018.Locarnini S Hatzakis A Chen DS Lok A Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs J Hepatol 201562S76 86 10.1016/j.jhep.2015.01.018Open DOISearch in Google Scholar

3 Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global burden of disease study 2010. Lancet. 2012;380:2095-128. doi: 10.1016/S0140-6736(12)61728-0.Lozano R Naghavi M Foreman K Lim S Shibuya K Aboyans V et al Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global burden of disease study 2010 Lancet 20123802095 128 10.1016/S0140-6736(12)61728-0Open DOISearch in Google Scholar

4 Schweitzer A, Horn J, Mikolajczyc RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546-55. doi: 10.1016/S0140-6736(15)61412-X.Schweitzer A Horn J Mikolajczyc RT Krause G Ott JJ Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 Lancet 20153861546 55 10.1016/S0140-6736(15)61412-XOpen DOISearch in Google Scholar

5 Coalition for global hepatitis elimination. Accessed January 26th, 2022 at: https://www.globalhep.org/country-progress/SloveniaCoalition for global hepatitis elimination Accessed January 26th 2022 https://www.globalhep.org/country-progress/SloveniaSearch in Google Scholar

6 Hahne JMS, Veldhuijzen IK, Wiessing L, Lim TA, Salminen M, Van de Laar M. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013;13:181–226. doi: 10.1186/1471-2334-13-181.Hahne JMS Veldhuijzen IK Wiessing L Lim TA Salminen M Van de Laar M Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening BMC Infect Dis 201313181 226 10.1186/1471-2334-13-181371689223597411Open DOISearch in Google Scholar

7 WHO. Combating Hepatitis B and C to reach elimination by 2030. Accessed March 7th, 2021 at: http://apps.who.int/iris/bitstream/10665/206453/1/WHO_HIV_2016.04_eng.pdfWHO. Combating Hepatitis B and C to reach elimination by 2030 Accessed March 7th, 2021 at http://apps.who.int/iris/bitstream/10665/206453/1/WHO_HIV_2016.04_eng.pdfSearch in Google Scholar

8 Cox AL, El-Sayed MH, Kao JH, Lazarus JV, Lemoine M, Lok AS, et al. Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020;9:533-42. doi: 10.1038/s41575-020-0332-6.Cox AL El-Sayed MH Kao JH Lazarus JV Lemoine M Lok AS et al Progress towards elimination goals for viral hepatitis Nat Rev Gastroenterol Hepatol 20209533 42 10.1038/s41575-020-0332-6737631632704164Open DOISearch in Google Scholar

9 Hutin Y, Desai S, Bulterys M. Preventing hepatitis B virus infections: milestones and targets. Accessed March 7th, 2021 at: https://www.who.int/bulletin/volumes/96/7/18-215210/en/Hutin Y Desai S Bulterys M Preventing hepatitis B virus infections: milestones and targets. Accessed March 7th 2021 https://www.who.int/bulletin/volumes/96/7/18-215210/en/10.2471/BLT.18.215210602261929962544Search in Google Scholar

10 WHO. Hepatitis B vaccines: WHO position paper, July 2017 – Recommendations. Vaccine. 2019;37:223-5. doi: 10.1016/j.vaccine.2017.07.046.WHO Hepatitis B vaccines: WHO position paper, July 2017 – Recommendations Vaccine 201937223 5 10.1016/j.vaccine.2017.07.04628743487Open DOISearch in Google Scholar

11 WHO. Status of new vaccine introduction – worldwide, September 2016. Accessed March 7th, 2021 at: http://apps.who.int/iris/bitstream/10665/252768/1/WER9201.pdf?ua=1WHO. Status of new vaccine introduction – worldwide, September 2016 Accessed March 7th, 2021 at http://apps.who.int/iris/bitstream/10665/252768/1/WER9201.pdf?ua=1Search in Google Scholar

12 Wang S, Cohen C, Tang AS, Graham CS. Hepatitis B virus elimination in the U.S.: Time to dismantle barriers and implement solutions. Curr Hepatol Report. 2021;20:34-42. doi: https://doi.org/10.1007/s11901-020-00557-3Wang S Cohen C Tang AS Graham CS Hepatitis B virus elimination in the U.S.: Time to dismantle barriers and implement solutions Curr Hepatol Report 20212034 42 https://doi.org/10.1007/s11901-020-00557-310.1007/s11901-020-00557-3Search in Google Scholar

13 Pravilnik o določitvi Programa cepljenja in zaščite z zdravili za leto 2021. Accessed January 26 th, 2022 at: https://www.nijz.si/sites/www.nijz.si/files/uploaded/pr.prog.ceplj_2021.pdfPravilnik o določitvi Programa cepljenja in zaščite z zdravili za leto 2021 Accessed January 26 th, 2022 at https://www.nijz.si/sites/www.nijz.si/files/uploaded/pr.prog.ceplj_2021.pdfSearch in Google Scholar

14 Official gazette of Rupublic of Slovenia. Pravilnik o cepljenju, zaščiti z zdravili in varstvu pred vnosom in razširjenjem nalezljivih bolezni. Accessed March 7th, 2021 at: https://www.uradni-list.si/1/content?id=18410Official gazette of Rupublic of Slovenia Pravilnik o cepljenju, zaščiti z zdravili in varstvu pred vnosom in razširjenjem nalezljivih bolezni. Accessed March 7th 2021 https://www.uradni-list.si/1/content?id=18410Search in Google Scholar

15 Seme K, Komloš Fujs K, Poljak M. Screening of pregnant women for hepatitis B virus infection. Med Razgl. 2006;45(Suppl3):123-6. Slovenian.Seme K Komloš Fujs K Poljak M Screening of pregnant women for hepatitis B virus infection Med Razgl 200645 Suppl3 123 6 SlovenianSearch in Google Scholar

16 ECDC. Antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA – addressing the vulnerable populations. 2017. Accessed March 7th, 2021 at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/antenatal-screening-sci-advice-2017.pdfECDC. Antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA – addressing the vulnerable populations. 2017 Accessed March 7th, 2021 at https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/antenatal-screening-sci-advice-2017.pdfSearch in Google Scholar

17 Collins English Dictionary. Origin. Accessed Juanuary 27th, 2022 at: https://www.collinsdictionary.com/dictionary/english/originCollins English Dictionary Origin. Accessed Juanuary 27th 2022 https://www.collinsdictionary.com/dictionary/english/originSearch in Google Scholar

18 EASL. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370-98. doi: 10.1016/j.jhep.2017.03.021EASL EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection J Hepatol 201767370 98 10.1016/j.jhep.2017.03.02128427875Open DOISearch in Google Scholar

19 Grasselli Kmet N, Poljak M, Rajter M, Selič T, Baklan Z, Pal E et al. Vaccination in the Yugoslav National Army: a significant risk factor for acquiring chronic hepatitis B virus infection during army service in former Yugoslavia. J Arch Mil Med 2020;8(4):e111950. Doi: 10.5812/jamm.111950.Grasselli Kmet N Poljak M Rajter M Selič T Baklan Z Pal E et al Vaccination in the Yugoslav National Army: a significant risk factor for acquiring chronic hepatitis B virus infection during army service in former Yugoslavia J Arch Mil Med 20208 4 e111950 10.5812/jamm.111950Open DOISearch in Google Scholar

20 ECDC. Systematic review on hepatitis B and C prevalence in the EU/ EEA. 2016. Accessed March 7th, 2021 at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/systematic-review-hepatitis-B-C-prevalence.pdfECDC. Systematic review on hepatitis B and C prevalence in the EU/ EEA. 2016 Accessed March 7th, 2021 at https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/systematic-review-hepatitis-B-C-prevalence.pdfSearch in Google Scholar

21 Van Damme P, Leuridan E, Hendrickx G, Vorsters A, Theeten H, Leino T, et al. Should Europe have universal hepatitis B vaccination programme? BMJ. 2013;346:f4057. doi:10.1136/bmj.f4057.Van Damme P Leuridan E Hendrickx G Vorsters A Theeten H Leino T et al Should Europe have universal hepatitis B vaccination programme? BMJ 2013346f4057 10.1136/bmj.f405723843546Open DOISearch in Google Scholar

22 WHO. Prevention of mother-to-child transmission of hepatitis B virus: guidelines onantiviral prophylaxis in pregnancy. 2020. Accessed March 7th, 2021 at: https://apps.who.int/iris/bitstream/handle/10665/333391/9789240002708-eng.pdf?sequence=1&isAllowed=yWHO. Prevention of mother-to-child transmission of hepatitis B virus: guidelines onantiviral prophylaxis in pregnancy. 2020 Accessed March 7th, 2021 at https://apps.who.int/iris/bitstream/handle/10665/333391/9789240002708-eng.pdf?sequence=1&isAllowed=ySearch in Google Scholar

23 Kojouharova M, Kurchatova A. Bulgaria: Impact of the universal newborn HBV vaccination programme: 20 years after. Viral hepatitis prevention board meeting. Milan, Italy, November 17-18, 2011. Accessed March 7th, 2021 at: http://www.vhpb.org/files/html/Meetings_and_publications/Presentations/MILS45.pdfKojouharova M Kurchatova A Bulgaria: Impact of the universal newborn HBV vaccination programme: 20 years after. Viral hepatitis prevention board meeting Milan, Italy November 17-18 2011 Accessed March 7th, 2021 at http://www.vhpb.org/files/html/Meetings_and_publications/Presentations/MILS45.pdfSearch in Google Scholar

24 Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology. 2007;132:1287–93. doi: 10.1053/j.gastro.2007.02.055.Ni YH Huang LM Chang MH Yen CJ Lu CY You SL et al Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies Gastroenterology 20071321287 93 10.1053/j.gastro.2007.02.05517433322Open DOISearch in Google Scholar

25 Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating hepatitis B disease, China. 2019. Accessed March 7th, 2021 at: https://www.who.int/bulletin/volumes/97/3/18-219469/en/Liu J Liang W Jing W Liu M Countdown to 2030: eliminating hepatitis B disease, China 2019 Accessed March 7th, 2021 at https://www.who.int/bulletin/volumes/97/3/18-219469/en/10.2471/BLT.18.219469645331130992636Search in Google Scholar

26 Chen DS. Hepatitis B vaccination: The key toward elimination and eradication of hepatitis B. J Hepatol. 2009;50:805-16. doi: 10.1016/j.jhep.2009.01.002.Chen DS Hepatitis B vaccination: The key toward elimination and eradication of hepatitis B J Hepatol 200950805 16 10.1016/j.jhep.2009.01.00219231008Open DOISearch in Google Scholar

27 Hadziyannis SJ. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. J Hepatol. 2011;55:183-91. doi: 10.1016/j.jhep.2010.12.030.Hadziyannis SJ Natural history of chronic hepatitis B in Euro-Mediterranean and African countries J Hepatol 201155183 91 10.1016/j.jhep.2010.12.03021238520Open DOISearch in Google Scholar

28 Wu JF, Chang MH. Natural history of chronic hepatitis B virus infection from infancy to adult life – the mechanism of inflammation triggering and long-term impacts. J Biomed Sci. 2015;22:92-116. doi: 10.1186/s12929-015-0199-y.Wu JF Chang MH Natural history of chronic hepatitis B virus infection from infancy to adult life – the mechanism of inflammation triggering and long-term impacts J Biomed Sci 20152292 116 10.1186/s12929-015-0199-y461823526487087Open DOISearch in Google Scholar